Squarepoint
IART icon

Squarepoint’s Integra LifeSciences IART Stock Holding History

Squarepoint’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$358K Buy
+21,979
New +$379K ﹤0.01% 3640
2025
Q3 		– Sell
-62,372
Closed -$765K – 4629
2025
Q2 		$765K Buy
+62,372
New +$906K ﹤0.01% 2901
2025
Q1 		– Sell
-25,285
Closed -$573K – 4951
2024
Q4 		$573K Sell
25,285
-64,458
-72% -$1.41M ﹤0.01% 3613
2024
Q3 		$1.63M Buy
+89,743
New +$2.08M ﹤0.01% 2214
2024
Q2 		– Sell
-12,993
Closed -$461K – 4327
2024
Q1 		$461K Sell
12,993
-26,150
-67% -$1.05M ﹤0.01% 3102
2023
Q4 		$1.7M Buy
+39,143
New +$1.54M ﹤0.01% 2122
2023
Q3 		– Sell
-6,647
Closed -$273K – 3996
2023
Q2 		$273K Sell
6,647
-5,127
-44% -$247K ﹤0.01% 3023
2023
Q1 		$676K Buy
+11,774
New +$663K ﹤0.01% 2129
2022
Q3 		– Sell
-4,698
Closed -$254K – 3181
2022
Q2 		$254K Buy
+4,698
New +$282K ﹤0.01% 2359
2022
Q1 		– Sell
-5,976
Closed -$400K – 3149
2021
Q4 		$400K Buy
+5,976
New +$404K ﹤0.01% 2298
2021
Q2 		– Sell
-19,597
Closed -$1.35M – 3437
2021
Q1 		$1.35M Buy
19,597
+2,471
+14% +$167K 0.01% 1296
2020
Q4 		$1.11M Buy
17,126
+4,685
+38% +$252K 0.01% 1264
2020
Q3 		$587K Buy
12,441
+2,542
+26% +$121K 0.01% 1310
2020
Q2 		$465K Buy
+9,899
New +$487K 0.01% 1352
2020
Q1 		– Sell
-29,106
Closed -$1.7M – 2152
2019
Q4 		$1.7M Buy
29,106
+20,929
+256% +$1.25M 0.01% 1003
2019
Q3 		$491K Sell
8,177
-30,273
-79% -$1.8M ﹤0.01% 1626
2019
Q2 		$2.15M Buy
38,450
+31,233
+433% +$1.61M 0.02% 805
2019
Q1 		$402K Sell
7,217
-58,016
-89% -$2.95M ﹤0.01% 1600
2018
Q4 		$2.94M Buy
65,233
+50,333
+338% +$2.76M 0.03% 558
2018
Q3 		$981K Sell
14,900
-136,174
-90% -$8.46M 0.01% 997
2018
Q2 		$9.7M Buy
151,074
+118,946
+370% +$7.37M 0.13% 232
2018
Q1 		$1.78M Buy
+32,128
New +$1.68M 0.03% 613

Other funds holding IART

Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Access Investment Management
Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Leeward Investments
Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return

Squarepoint's IART Position: Q3 2026 in Review

Squarepoint opened a new position in Integra LifeSciences (IART) in Q3 2026: 21,979 shares worth $358K. The stake represents ﹤0.01% of the portfolio and ranks #3640 among its holdings. This is a return to the name: Squarepoint previously reported a position in IART as recently as Q2 2025.

Squarepoint first reported a position in IART in Q1 2018 and has held it in 22 quarters since. The position peaked at $9.7M in Q2 2018. 142 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Squarepoint held 21,979 shares of Integra LifeSciences worth $358K as of Q3 2026.
  • Integra LifeSciences was a new Squarepoint position in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3640 holding.
  • Squarepoint first reported a position in Integra LifeSciences in Q1 2018 and has held it in 22 quarters since.
  • Squarepoint's Integra LifeSciences position peaked at $9.7M in Q2 2018.
  • 142 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.